Takuya Yoshimoto

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 3

Top Topics

Metastatic Colorectal Cancer

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Pharmaceutical statistics

NPJ precision oncology

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Takuya Yoshimoto, Satoru Shinoda, Kouji Yamamoto, Kouji Tahata
Bayesian Predictive Probability Based on a Bivariate Index Vector for Single-Arm Phase II Study With Binary Efficacy and Safety Endpoints. Pharmaceutical statistics (2024)
Koh Furugaki, Takaaki Fujimura, Hayato Mizuta, Takuya Yoshimoto, Takashi Asakawa, Yasushi Yoshimura, Shigeki Yoshiura
FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes. NPJ precision oncology 7 (1) (2023)
Yusuke Narita, Takuya Yoshimoto, Tomoyuki Namai, Takashi Asakawa, Satoe Kawakami, Craig Gower-Page, Irmarie Reyes-Rivera, Arisha Patel, Yoshiaki Nakamura
Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2 -Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm. JCO clinical cancer informatics 6 (2022)